Johann Gudjonsson, MD, PhD

home / authors / johann-gudjonsson-md-phd

Arthur C Curtis Professor of Skin Molecular Immunology, Professor of Dermatology, Professor of Internal Medicine and Research, University of Michigan Medical School

Articles

Johann Gudjonsson, MD, PhD, on Emerging AD Therapies: From Single Targets to Combination Approaches

Sydney Jennings;Johann Gudjonsson, MD, PhD

June 19th 2025

RAD 2025: Johann Gudjonsson, MD, PhD, on investigational AD treatments, including anti–IL-31 receptor antibodies, anti–IL-13 treatments, IL-4 receptor blockers, JAK inhibitors, and new topical agents.

Johann Gudjonsson, MD, PhD: Role of OX-40 Pathway in Atopic Dermatitis Pathogenesis

Johann Gudjonsson, MD, PhD;Sydney Jennings

June 18th 2025

Johann Gudjonsson, MD, discusses how OX-40/OX-40L signaling drives immune activation in AD and its emerging role as a genetic and therapeutic target.

Why the OX-40/OX-40L Pathway Matters in Atopic Dermatitis—and What’s Next: A Q&A with Johann Gudjonsson, MD, PhD

Sydney Jennings;Johann Gudjonsson, MD, PhD

June 12th 2025

At RAD 2025, Johann Gudjonsson, MD, PhD, discussed the OX-40 pathway’s role in AD, genetic links to disease risk, and promising combination therapies in development.